Optrex Infected Eye Drops (Chloramphenicol)

Chloramphenicol inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, blocking the peptidyl transferase step essential for forming new proteins. This bacteriostatic action halts bacterial replication in the ocular tissues, allowing the immune system to clear the infection while minimizing inflammation.

The dosing regimen for Optrex Infected Eye Drops is determined by the prescribing healthcare professional based on the severity of the infection, patient age and response to therapy. Typically, a few drops are instilled into the affected eye(s) at prescribed intervals, and the exact schedule should be followed as directed by the prescriber.

Chloramphenicol is classified as Pregnancy Category C, meaning it should only be used when the potential benefit outweighs any possible risk to the fetus. It can be excreted in breast milk, so caution is advised for nursing mothers. The prescriber will evaluate the risk‑benefit profile before recommending use in these populations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Optrex Infected Eye Drops (chloramphenicol) offers a broad spectrum of activity against many Gram‑positive and Gram‑negative ocular pathogens and is well‑tolerated when used short‑term. Alternatives such as tobramycin or fusidic acid may have a narrower spectrum or different resistance profiles. Choice of therapy depends on local antibiograms, patient tolerance and prescriber preference.

The product should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed in its original packaging until use. Do not freeze the drops, and discard any solution that appears discolored or cloudy after the labeled expiry date.

Before instillation, wash hands thoroughly and avoid touching the tip of the bottle. Tilt the head back, gently pull down the lower eyelid to form a pocket, and place the prescribed number of drops into the conjunctival sac. Close the eye gently for a few seconds, then repeat for the other eye if directed. Do not rinse the eye immediately after dosing.

While most reactions are mild, serious adverse events can include severe allergic responses such as angioedema or contact dermatitis, significant eye pain or worsening vision, and, very rarely, systemic bone‑marrow suppression leading to aplastic anemia. Patients should seek immediate medical attention if they experience any of these severe symptoms.

Optrex Infected Eye Drops should be avoided in individuals with a known hypersensitivity to chloramphenicol or other phenicol antibiotics. It is also contraindicated in patients with pre‑existing bone‑marrow disorders and should be used with caution in pregnant or breastfeeding women, as well as in those requiring prolonged therapy.